Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03526432 · ClinicalTrials.gov registry record · Phase 2

Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

A Phase 2 study of Endometrial Cancer, sponsored by University of Oklahoma.

Active
Registry status
Phase 2
Development phase
110
Enrollment target
3
Study locations

NCT03526432 is a Phase 2 study of Endometrial Cancer that is active but no longer recruiting, run by University of Oklahoma. The registered enrollment target is 110 participants, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (79% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03526432, a Phase 2 study of Endometrial Cancer, is active but no longer recruiting, sponsored by University of Oklahoma.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
110 participants
Enrollment target
3
Study locations

Study Summary

This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial cancer. Safety and futility of this drug combination will be assessed to see what effect this treatment has on this patient population.

Conditions Studied

Endometrial Cancer

Interventions

  • DRUG Bevacizumab
  • DRUG Atezolizumab

Study Locations (3)

Alabama

  • UAB Women and Infants Center - Birmingham

Missouri

  • Washington University School of Medicine - St Louis

Oklahoma

  • Stephenson Cancer Center, University of Oklahoma Health Sciences Center - Oklahoma City

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2018-08-08
Est. Completion 2026-09
Phase Phase 2

Sponsor

University of Oklahoma

358 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03526432

The ClinicalTrials.gov registry entry for NCT03526432 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (79% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 2 interventions - of which Bevacizumab is the first listed.

NCT03526432 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Alabama, Missouri, Oklahoma.

Frequently Asked Questions

What is clinical trial NCT03526432 about?

NCT03526432 is a clinical study titled "Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer". This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial cancer. Safety and futility of this drug combination will be assessed to see what effect this treatment has on this patient population.

What is the current status of trial NCT03526432?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2018-08-08. Estimated completion is 2026-09.

What conditions does trial NCT03526432 study?

This clinical trial studies the following conditions: Endometrial Cancer.

What interventions are being tested in trial NCT03526432?

The interventions under investigation include: Bevacizumab (DRUG), Atezolizumab (DRUG).

Who is sponsoring clinical trial NCT03526432?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03526432 being conducted?

This trial has 3 study locations across Alabama, Missouri, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Endometrial Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Endometrial Cancer

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.